Takeda's pipeline continues to shift towards oncology
15 February 2010
Ian Haydock
Please Login to read the full article.
15 February 2010
Ian Haydock
ian.haydock@informa.com
Takeda has given further details of two new in-house projects in early clinical development in the oncology area, which signal its increasing research emphasis on this therapeutic sector.
The Japanese firm is looking to build up its presence in cancer given the growth in the field in general...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Astellas mulls darexaban alliances as pipeline moves forward
- GSK to close three research units, open four more amid hopes for sales growth in 2012
- Iron chelator, prostate cancer conundrum on deck for ODAC
- Ardea seeks $144.5M in public offering as it advances PhIII oral gout drug
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
